SCHEMBL5568896

SCHEMBL5568896

[CH2]CCC(C)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9559788 0.83
SCHEMBL21708235 0.81
SCHEMBL10522453 0.81 TSHR (0.34)
SCHEMBL2382620 0.75
SCHEMBL28617279 0.75 TSHR (0.36)
SCHEMBL6740341 0.75 TSHR (0.36)
SCHEMBL11498533 0.74
SCHEMBL6439082 0.74
SCHEMBL13263355 0.74
SCHEMBL451420 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106715430-A Inhibition of transient receptor potential A1 ion channels 海德拉生物科学公司 2017-05-24 CN claimed
CN-102153562-B Spiro-oxindole compounds and their uses as therapeutic agents XENON PHARMACEUTICALS INC 2015-05-13 CN claimed
EP-0191542-A1 Arylcyclobutylalkyl amines and their use as antidepressive medicines The Boots Company PLC (GB) 1986-08-20 EP claimed
CN-106715430-B inhibition of transient receptor potential A1 ion channels 伊莱利利公司 2019-09-17 CN disclosed
CN-106715430-A Inhibition of transient receptor potential A1 ion channels 海德拉生物科学公司 2017-05-24 CN disclosed
EP-1819693-A1 ANTITHROMBOTIC DIAMIDES ELI LILLY AND COMPANY (US) 2007-08-22 EP disclosed
WO-2006057868-A1 ANTITHROMBOTIC DIAMIDES ELI LILLY AND COMPANY (US) 2006-06-01 WO disclosed
EP-0191542-A1 Arylcyclobutylalkyl amines and their use as antidepressive medicines The Boots Company PLC (GB) 1986-08-20 EP disclosed